Skip to main content

R&D
3A labs
Accunea
Adaptate Therapeutics
ADC Therapeutics
Adendra Therapeutics
Akari Therapeutics
AstronauTx
Autolus
AviadoBio
Avvinity
Axovia Therapeutics
Baseimmune
BioMoti 
Biotecnol
Braincures
BUGS Bioscience
Canbex Therapeutics 
Cellinta
Champions Oncology
Curileum Discovery
deltadot
DNAe
Eli Lilly
Ellipses Pharma
Engitix Therapeutics
Eurofins Genomics
Evelo Biosciences
GammaDelta
GeneAlpha
GlamorousAI
Haoma Medica
HAV Vaccines
hVivo
Immodulon Therapeutics 
ImmuPharma 
Intract Pharma
iQur 
Isomorphic lab
Istesso
J&J
Kuur Therapeutics
LifeBit
Mavalon Therapeutics
MeiraGTx
Mereo Biopharma
Micorsens biotech
MiNA Therapeutics
MSD
Nalia systems
Nanomerics
Novalgen
Orchard Therapeutics
Oribiotech
Phaim
Pharmidex
Prokarium
Proxima Concepts
Pulmocide 
Purespring Therapeutics
Quell Therapeutics
Rare Biotech 
Rexgenero
Roche
SEEK
Shield Therapeutics
Silence Therapeutics
SLA Pharma
Spirogen
Sporegen
SwanBio
Synthace
Tecrea
Thiologics
Tiziana
Topivert
Valirx  
Vasgen
Verona Pharma 
Viiv Healthcare
Viramatix
Virokine Therapeutics
Virtus Respiratory Research
Yaqrit
Zarodex

 

Research
Birkbeck College
The Institute of Cancer Research 
Imperial College London
King's College London
Queen Mary University
The Crick Institute

 

TT and Investors
4BioCapital
Advent Life Sciences
Arix Bioscience
Flerie Investment
IP Group
King's College Commercialisation
LifeArc
Parkwalk
Sixth Element Capital
SROne
SV Life Sciences
Syncona 
Silicon Valley Bank
Syndicate Room
Touchstone Innovations